Despite these reports supporting the pro-tumorigenic role of the NLRP3 inflammasome, we should note that research has additionally indicated a tumor-protective role in certain cancers, such as colitis-associated cancer [16], colorectal cancer [17], hepatocellular carcinoma [18], and melanoma [19]. The gene discussed is NLRP3; the disease is melanoma.